Redx signs licensing agreement with AstraZeneca for porcupine inhibitor

AstraZeneca will take RXC006 forward into clinical development, targeting fibrotic diseases including idiopathic pulmonary fibrosis

picture of

Breaking News

Hovione to support production of antiviral Veklury for COVID-19

Hovione has signed a partnership agreement with Ligand to significantly ramp up the production output of Captisol

Roquette names Barentz a strategic partner for US distribution

Distributor will carry the entire Roquette pharmaceutical portfolio for customers in the United States

Isotope producer expands benzene and bromobenzene capacities

Cambridge Isotope Laboratories has recently announced a capacity expansion for deuterated benzene

Identifying nitrosamines in pharmaceutical products

The TEA detector has long been an industry standard for nitrosamine analysis in food and beverages, which can also be ...

Seqens inaugurates new HPAPI unit at French site

The new unit is a result of a $35 million investment in one of the three leading technologies in pharmaceutical ...

AbCellera acquires OrthoMab bispecific platform

AbCellera has acquired the OrthoMab bispecific platform from Dualogics

Manufacturing pressure accelerates move to fully formulated film coatings

Why now is the right time to change to a leaner system, explains Colorcon's Dr Jason Teckoe, Technical Director, EMEA

Japanese CDMO to invest $100m in capacity and portfolio

Bushu Pharmaceutical's new facility is an important component in the company's "Asia hub" strategy

Tetra Bio-Pharma engages Dalton Pharma for GMP manufacturing

Tetra Bio-Pharma has awarded the contract for the manufacturing of its active pharmaceutical ingredient ARDS-003

Nitrosamines: Information for Marketing Authorisation Holders

Nitrosamine impurities have been in the regulatory spotlight since they were discovered in several blood pressure ...

Overcoming the excipient challenge with a multifunctional filler-binder

Dr Maj-Britt Cepok, Head of Business Development Pharma at BENEO, talks to Dr Kevin Robinson about trends in excipients ...

The Lonza powder-in-capsule microdosing approach

Jeff Williamson and Ben Sahacic explain how microdosing offers a proven approach for biopharmaceutical companies to ...

Kodak announces $765m initiative to create Kodak Pharmaceuticals

Kodak Pharmaceuticals would have the capacity at Eastman Business Park to produce up to 25% of active pharmaceutical ...

The Native Antigen Company introduces custom service for influenza antigens

The reagent supplier has announced the introduction of its custom contract service to rapidly develop antigen panels ...